Singapore firm starts new Alzheimer's drug trials
LONDON (Reuters) - TauRx Therapeutics, a privately held biotech company based in Singapore, has launched two late-stage clinical studies testing a new kind of experimental drug against Alzheimer's. Its LMTX drug aims to attack the memory-robbing disease by blocking the build-up of a protein called tau that forms twisted fibers and tangles inside brain cells. Many scientists believe tau is an important cause of Alzheimer's, alongside another protein known as amyloid that has been the main focus of drug development efforts to date. ...
Source: news.yahoo.com
No comments:
Post a Comment